cprx stock price target
According to 11 stock analysts the average 12-month stock price forecast for CPRX stock is 1724 which predicts an increase of 2262. CPRX analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.
Why Catalyst Pharmaceuticals Cprx Is A 6 Stock
6 hours agoCPRX stock popped in after-hours action as Catalyst Pharma beat EPS and revenue views.
. Know When To Sell Your Stocks. Ad Tiny company is a sneaky EV play that no ones talking about but should be. The average price target is.
A price target is a stock market term used by investors and analysts to indicate the level at which they believe a stock will trade. The average price target represents an increase of 202 from the last closing price of 1406. Catalyst Pharmaceuticals Stock Performance.
Its official - this tiny company is ready to dominate for the next 10 years. These targets are based on 21 analysts price predictions made in the past three months for CPRX over the next 12 months. Based On Fundamental Analysis.
Shares of CPRX opened at 1533 on Wednesday. 4 analyst firms have reported ratings in the last year. According to 11 analysts the average rating for CPRX stock is Buy The 12-month stock price forecast is 1724 which is an increase of 2262 from the latest price.
Catalyst CPRX delivered earnings and revenue surprises of 526 and 640 respectively for the quarter ended September 2022. The company has a 50-day simple moving average of 1346 and a 200-day simple moving average of 1046. 1096 Upside Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months.
The price target is based on several factors. An Industry Subrating of High. A target price of 15000000.
Discover the Power of thinkorswim Today. Stock Price Forecast The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1700 with a high estimate of 1800 and a low. CPRX stock quote history news and other vital information to help you with your stock trading and investing.
Catalyst stock fell 535 on. The biotech also implied Q4 sales in line with consensus. Find the latest Catalyst Pharmaceuticals Inc.
Ad 1000 Strong Buy Stocks that Double the SP. CATALYST PHARMACEUTICALS INCs variance in analysts estimates is lower than -1653 of. Do the numbers hold clues to what lies.
Shares of CPRX opened at 1533 on Wednesday. CPRX Stock Price Prediction. According to 3 Wall Street analyst s that have issued a 1 year CPRX price target the average CPRX price target is 1683 with the highest CPRX stock price forecast at 1800 and the.
The target price for CPRX stock is 1690 based on the average of what a group of analyst think CPRX stock could be worth at a future date. 20 2019 at 759 am. Catalyst Pharma stock forecast analyst price target predictions based on 5 analysts offering 12-months price targets for CPRX in the last 3 months.
Lowering target price to. CPRX has a higher average analyst price target than 11248 of all US stocks. Catalyst Pharmaceuticals stock price target raised to 10 from 9 at Oppenheimer Mar.
Analyst ratings historical stock prices earnings estimates actuals. ET by Tomi Kilgore Catalyst Pharmaceuticals started at outperform. Lowering target price to 1500CATALYST PHARMACEUTICALS INC has an Investment Rating of BUY.
CPRX updated stock price target summary. With a pricesales ratio of 843. The lowest target is 1566 and.
The analyst firm set a price target for 1200 expecting CPRX to fall to within 12 months a possible -1465 downside. The company has a 50-day simple moving average of 1346 and a 200-day. The forecasts range from a low of 1550 to a high of 1800.
For CPRX its debt to operating expenses ratio is greater than that reported by only 1102 of US equities were observing. Find the latest Catalyst Pharmaceuticals Inc.
Biotech Stocks Notch A Blazing Path In 2022 Why The Good Times Aren T Over Investor S Business Daily
Cprx Bmy Insiders Are Selling These 2 Pharma Stocks Should You
Catalyst Pharmaceuticals Stock Nasdaq Cprx Quotes And News Summary Benzinga
7 Penny Stocks That Wall Street Thinks Are Undervalued Investorplace
Catalyst Pharmaceuticals Nasdaqcm Cprx Share Price News Analysis Simply Wall St
3 Popular Robinhood Penny Stocks To Buy Under 5
Is Catalyst Pharmaceutical Partners Inc Cprx A Buy After Its Promising Results In Proof Of Concept Trial Of Vigabatrin Insider Monkey
Cprx Bmy Insiders Are Selling These 2 Pharma Stocks Should You
Got 2 500 These 2 Small Cap Monsters Are Crushing Tesla Stock The Motley Fool
Catalyst Pharmaceuticals Cprx Rallies 80 69 Ytd Here S Why
Top Penny Stocks On Robinhood With High Analyst Ratings
Is Catalyst Pharmaceuticals Inc Cprx Stock A Attractive Value
Cprx Bmy Insiders Are Selling These 2 Pharma Stocks Should You Nasdaq
Catalyst Pharmaceuticals Performing Above Expectations Nasdaq Cprx Seeking Alpha